Poly Medicure Limited (POLYMED) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.031x

Based on the latest financial reports, Poly Medicure Limited (POLYMED) has a cash flow conversion efficiency ratio of 0.031x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs914.43 Million ≈ $9.89 Million USD) by net assets (Rs29.32 Billion ≈ $317.14 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Poly Medicure Limited - Cash Flow Conversion Efficiency Trend (2006–2025)

This chart illustrates how Poly Medicure Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Poly Medicure Limited (POLYMED) total liabilities for a breakdown of total debt and financial obligations.

Poly Medicure Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Poly Medicure Limited ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Veritex Holdings Inc
NASDAQ:VBTX
0.017x
Sparebank 1 Nord-Norge
OL:NONG
0.132x
Playa Hotels & Resorts BV
NASDAQ:PLYA
0.147x
Ningbo Ocean Shipping Co. Ltd. A
SHG:601022
N/A
SLC Agrícola S.A
SA:SLCE3
0.152x
Sobha Limited
NSE:SOBHA
0.063x
S&T Bancorp Inc
NASDAQ:STBA
0.028x
PT Arkora Hydro Tbk
JK:ARKO
-0.153x

Annual Cash Flow Conversion Efficiency for Poly Medicure Limited (2006–2025)

The table below shows the annual cash flow conversion efficiency of Poly Medicure Limited from 2006 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Poly Medicure Limited worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 Rs27.66 Billion
≈ $299.10 Million
Rs2.40 Billion
≈ $26.00 Million
0.087x -51.97%
2024-03-31 Rs14.70 Billion
≈ $158.98 Million
Rs2.66 Billion
≈ $28.78 Million
0.181x +17.77%
2023-03-31 Rs12.42 Billion
≈ $134.28 Million
Rs1.91 Billion
≈ $20.64 Million
0.154x +35.36%
2022-03-31 Rs10.87 Billion
≈ $117.61 Million
Rs1.23 Billion
≈ $13.35 Million
0.114x -7.67%
2021-03-31 Rs9.66 Billion
≈ $104.42 Million
Rs1.19 Billion
≈ $12.84 Million
0.123x -59.03%
2020-03-31 Rs4.35 Billion
≈ $47.02 Million
Rs1.31 Billion
≈ $14.11 Million
0.300x +6.85%
2019-03-31 Rs3.81 Billion
≈ $41.24 Million
Rs1.07 Billion
≈ $11.58 Million
0.281x +26.82%
2018-03-31 Rs3.38 Billion
≈ $36.59 Million
Rs749.28 Million
≈ $8.10 Million
0.221x +4.36%
2017-03-31 Rs2.64 Billion
≈ $28.59 Million
Rs561.17 Million
≈ $6.07 Million
0.212x -23.46%
2016-03-31 Rs2.29 Billion
≈ $24.73 Million
Rs633.95 Million
≈ $6.86 Million
0.277x -14.07%
2015-03-31 Rs1.96 Billion
≈ $21.22 Million
Rs633.05 Million
≈ $6.85 Million
0.323x -27.89%
2014-03-31 Rs1.46 Billion
≈ $15.84 Million
Rs655.39 Million
≈ $7.09 Million
0.447x +29.58%
2013-03-31 Rs1.12 Billion
≈ $12.16 Million
Rs388.35 Million
≈ $4.20 Million
0.345x -2.14%
2012-03-31 Rs935.63 Million
≈ $10.12 Million
Rs330.19 Million
≈ $3.57 Million
0.353x +17.52%
2011-03-31 Rs781.74 Million
≈ $8.45 Million
Rs234.75 Million
≈ $2.54 Million
0.300x -14.34%
2010-03-31 Rs606.36 Million
≈ $6.56 Million
Rs212.56 Million
≈ $2.30 Million
0.351x +23.52%
2009-03-31 Rs479.72 Million
≈ $5.19 Million
Rs136.15 Million
≈ $1.47 Million
0.284x +20.42%
2008-03-31 Rs420.98 Million
≈ $4.55 Million
Rs99.21 Million
≈ $1.07 Million
0.236x -26.52%
2007-03-31 Rs349.99 Million
≈ $3.79 Million
Rs112.25 Million
≈ $1.21 Million
0.321x -21.19%
2006-03-31 Rs278.57 Million
≈ $3.01 Million
Rs113.36 Million
≈ $1.23 Million
0.407x --

About Poly Medicure Limited

NSE:POLYMED India Medical Instruments & Supplies
Market Cap
$1.66 Billion
Rs153.27 Billion INR
Market Cap Rank
#6966 Global
#312 in India
Share Price
Rs1512.10
Change (1 day)
-0.38%
52-Week Range
Rs1191.10 - Rs2835.20
All Time High
Rs3128.90
About

Poly Medicure Limited engages in the manufacture and sale of medical devices in India and internationally. The company offers infusion therapy products, such as I.V Infusion set, extension lines, needle free connector, I.V flow regulator extension set, burette set, three way stop cock, vial access spike, transfer spike, orburator, polyflush, maifolds, polyswab, and arterial blood collection; crit… Read more